Submit Phase III CT data with Pk and Pd data: CDSCO Panel Tells Intas Pharmaceuticals on Human von Willebrand Factor Dr. Divya Colin12 April 2025 5:30 AM ISTNew Delhi: In response to the proposal for the grant of permission to manufacture Human von Willebrand Factor EP 600 IU (Freeze Dried Powder) Drug...
Intas Pharmaceutical Gets CDSCO Panel Nod To Conduct Phase III clinical trial of Fibrogen-I Dr. Divya Colin10 April 2025 6:15 PM ISTNew Delhi: Intas Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Intas Pharmaceuticals Gets CDSCO Panel Nod To study Bevacizumab Solution for Injection Dr. Divya Colin12 March 2025 5:45 PM ISTNew Delhi: Intas Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Intas Pharmaceutical Gets CDSCO Panel Nod To Manufacture, Market Anti-cancer Drug Pertuzumab Dr. Divya Colin1 Dec 2024 5:45 PM ISTNew Delhi: Intas Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Intas Pharmaceuticals Gets CDSCO Panel Nod to Study R-hFSH Solution for Injection Dr. Divya Colin10 Nov 2024 6:00 PM ISTNew Delhi: Intas Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Intas Pharmaceutical Gets CDSCO Panels Nod to Conduct Phase III clinical trial of Ruxolitinib cream Dr. Divya Colin3 Nov 2024 5:00 PM ISTNew Delhi: Intas Pharmaceutical has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Intas Pharmaceuticals Gets CDSCO Panel Nod to Study Vedolizumab for Ulcerative Colitis Dr. Divya Colin13 Aug 2024 6:00 PM ISTNew Delhi: Intas Pharmaceuticals has got the go-ahead from the Subject Expert Committee ( SEC) functional under the Central Drug Standard Control...
Demonstrate safety and adequacy of dose: CDSCO Panel Tells Intas Pharmaceuticals on Bevacizumab injection Dr. Divya Colin16 Jun 2024 6:00 PM ISTNew Delhi: Reviewing the justification presented by the drug major Intas Pharmaceuticals for not conducting the initial phase of clinical studies of...
CDSCO Panel grants Intas Pharma's proposal for additional pack of Romiplostim Injection 125 mcg/vial Dr. Divya Colin16 Jan 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Intas Gets CDSCO Panel Nod To Manufacture, Market Tacrolimus Liquid Tablets Dr. Divya Colin18 Aug 2023 6:00 PM ISTNew Delhi: The drug major Intas Pharmaceutical has got approval from the Subject Expert Committee ( SEC) functional under the Central Drug Standard...
